Effect of Dexmedetomidine on the Quality of Recovery in Parturients Undergoing Elective Caesarean Sections

PHASE4CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

December 31, 2022

Conditions
The Quality of Recovery (ObsQOR-11)
Interventions
DRUG

Dexmedetomidine

"All patients will be assessed clinically and investigated for exclusion of any of the above-mentioned contraindications. The required laboratory work will be: complete blood count (CBC); prothrombin time and concentration (PT\&PC); partial thromboplastin time (PTT); bleeding time (BT); clotting time (CT); liver function tests and kidney function tests.~Before arrival to the operation room (OR), women will be premedicated by metoclopramide 10mg and ranitidine 50 mg intravenous. Intra operatively, hemodynamics will be recorded baseline before spinal anaesthesia , after its performance, every 3 minutes until delivery and then every 10 minutes till the end of the CS. Any change within 20% of baseline will be accepted and any changes more than 20% will be managed according to guidelines. All groups will be anaesthetized to preform CS with conventional spinal anaesthesia. The TAP block group will receive a landmark orientated Ultrasound guided bilateral TAP block."

Trial Locations (1)

11562

Faculty of Medicine, Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT05991466 - Effect of Dexmedetomidine on the Quality of Recovery in Parturients Undergoing Elective Caesarean Sections | Biotech Hunter | Biotech Hunter